Clover Health Investments... (CLOV)
NASDAQ: CLOV
· Real-Time Price · USD
2.67
0.10 (3.89%)
At close: Aug 15, 2025, 12:41 PM
Clover Health Investments Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.61B | 1.49B | 1.37B | 1.54B | 1.52B | 1.48B | 1.46B | 1.85B | 2.4B | 2.92B | 3.48B | 3.01B | 2.58B | 2.15B | 1.47B | 1.21B | 948.1M | 707.71M |
Cost of Revenue | 1.22B | 1.09B | 1.01B | 1.21B | 1.2B | 1.19B | 1.2B | 1.65B | 2.25B | 2.87B | 3.45B | 3B | 2.6B | 2.2B | 1.55B | 1.29B | 997.31M | 658.17M |
Gross Profit | 383.65M | 391.93M | 364.8M | 333.15M | 322.18M | 290.14M | 255.59M | 198.47M | 145.24M | 57.28M | 22.73M | 7.82M | -18.36M | -52.3M | -79.06M | -82.6M | -49.21M | 49.53M |
Operating Income | -42.07M | -24.32M | -45.75M | -89.96M | -114.79M | -150.86M | -207.86M | -249.36M | -289.84M | -363.68M | -371.47M | -451.09M | -526.25M | -605.38M | -636.99M | -517.83M | -390.2M | -185.16M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -42.12M | -24.37M | -46.27M | -95.26M | -120.09M | -156.15M | -212.68M | -226.25M | -268.12M | -343.6M | -339.39M | -442.54M | -401.58M | -614.83M | -587.76M | -526.95M | -479.66M | -156.65M |
Net Income | -43.1M | -25.11M | -43.01M | -91.39M | -123.7M | -159.93M | -213.36M | -226.94M | -260.95M | -336.5M | -339.39M | -442.54M | -401.58M | -614.83M | -587.76M | -526.95M | -479.66M | -156.65M |
Selling & General & Admin | 424.71M | 414.84M | 408.93M | 403.84M | 415.24M | 419.46M | 442.3M | 456.72M | 473.1M | 486.48M | 486.64M | 476.5M | 477.74M | 468.02M | 445.87M | 386.61M | 313.88M | 246.76M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1M | 1.41M | 1.62M | 19.27M | 21.73M | 21.54M | 21.15M | -8.89M | -38.01M | -65.51M | -92.44M | -17.59M | 30.16M | 85.06M | 112.06M | 48.62M | 27.11M | -12.06M |
Operating Expenses | 425.71M | 416.25M | 410.55M | 423.11M | 436.97M | 441.01M | 463.44M | 447.83M | 435.08M | 420.96M | 394.2M | 458.92M | 507.89M | 553.08M | 557.94M | 435.24M | 340.99M | 234.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 7K | 7K | 146K | 559K | 960K | 1.36M | 1.64M | 1.65M | 2.48M | 16.91M | 33.11M | 46.36M | 58.42M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.65B | 1.51B | 1.42B | 1.63B | 1.63B | 1.63B | 1.67B | 2.1B | 2.69B | 3.29B | 3.85B | 3.46B | 3.11B | 2.75B | 2.11B | 1.72B | 1.34B | 892.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 508.89M | 497.06M | 491.87M | 490.18M | 487.48M | 486.37M | 481.61M | 480.77M | 479.16M | 478.81M | 477.9M | 477.69M | 476.06M | 473.03M | 470.85M | 420.63M | 408.31M | 376.17M |
Shares Outstanding (Diluted) | 508.89M | 497.06M | 491.87M | 490.18M | 495.18M | 567.45M | 481.61M | 480.77M | 479.16M | 478.81M | 477.9M | 477.69M | 476.06M | 473.03M | 470.85M | 420.63M | 408.31M | 376.17M |
EPS (Basic) | -0.09 | -0.06 | -0.09 | -0.2 | -0.27 | -0.34 | -0.45 | -0.48 | -0.55 | -0.71 | -0.72 | -0.94 | -0.86 | -1.42 | -1.39 | -1.19 | -1.08 | -0.29 |
EPS (Diluted) | -0.09 | -0.06 | -0.09 | -0.2 | -0.27 | -0.34 | -0.45 | -0.48 | -0.55 | -0.71 | -0.72 | -0.94 | -0.86 | -1.42 | -1.39 | -1.19 | -1.08 | -0.29 |
EBITDA | -40.58M | -22.89M | -44.12M | -92.78M | -117.39M | -152.77M | -208.35M | -223.3M | -264.7M | -340.19M | -336.84M | -438.03M | -397.55M | -610.44M | -569.6M | -493.3M | -432.74M | -97.64M |
EBIT | -42.12M | -24.37M | -45.45M | -94.44M | -119.27M | -155.32M | -210.86M | -224.3M | -265.76M | -340.83M | -338.02M | -440.91M | -399.93M | -612.35M | -570.85M | -493.83M | -433.3M | -98.23M |
Depreciation & Amortization | 1.54M | 1.48M | 1.33M | 1.66M | 1.88M | 2.55M | 2.51M | 994K | 1.05M | 640K | 1.19M | 2.88M | 2.38M | 1.91M | 1.25M | 540K | 558K | 593K |